ProHealth fibromyalgia Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

The Crucial Role CoQ10 Plays in Fibromyalgia and ME/CFS

Meditation, Cortisol, and Fibromyalgia

Progression of fibromyalgia: results from a 2-year observational fibromyalgia and chronic pain study...

Will a Gluten-free Diet "Fix" Fibromyalgia?

The Exercise Intolerance in POTS, ME/CFS and Fibromyalgia Explained?

The Twins: Fibromyalgia / PTSD

#ISpeakForPain Blitz

5 Ways That I Reduce Stress During Tough Times

VIDEO: Medical Marijuana Use of Fibromyalgia Patients

Move More: How I Actually Started Exercising with a Chronic Condition

 
Print Page
Email Article

Contrasting Case Definitions: The ME International Consensus Criteria vs. the Fukuda et al. CFS Criteria

  [ 3 votes ]   [ Discuss This Article ]
By Abigail A. Brown et al. • www.ProHealth.com • May 18, 2013


Editor's Comment: The authors of this study selected a group of 114 patients who met the CDC "Fukuda" case definition and then determined how many of them met the International Consensus (ICC) criteria. The subset that met the ICC criteria were more functionally impaired, and also had higher psychiatric comorbitities.The authors concluded that "based on the present analyses, the ME-ICC criteria appear to select a more functionally impaired and symptomatic group of individuals, with regards to both mental and physical health." While the ICC group had a higher rate of psychiatric diagnoses, it should be kept in mind that any patient presenting with a wide variety of medically unexplained symptoms will automatically receive a psychiatric diagnosis of somatization disorder. Rather than call into question the validity of the ICC, this study may simply point to a fundamental flaw in the nature of psychiatric diagnoses.

Note: The full article can be accessed from the abstract.

By Abigail A Brown et al.

This article contrasts the Myalgic Encephalomyelitis International Consensus Criteria (ME-ICC; Carruthers et al., 2011) with the Fukuda et al. (1994) CFS criteria. Findings indicated that the ME-ICC case definition criteria identified a subset of patients with more functional impairments and physical, mental and cognitive problems than the larger group of patients meeting the Fukuda et al. (1994) criteria. The sample of patients meeting ME-ICC criteria also had significantly greater rates of psychiatric comorbidity. These findings suggest that utilizing the MEICC may identify a more homogenous group of individuals with more severe symptomatology and functional impairment. Implications of the high rates of psychiatric comorbidity found in the ME-ICC sample are discussed.

Source: North American Journal of Psychology;2013, Vol. 15 Issue 1, p103. March 2013. Brown, Abigail A.; Jason, Leonard A.; Evans, Meredyth A.; Flores, Samantha





Post a Comment

Featured Products From the ProHealth Store
B-12 Extreme™ Energy NADH™ 12.5mg Hydroxocobalamin Extreme™

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
Natural Pain Relief Supplements

Featured Products

Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Fibro Freedom™ Fibro Freedom™
Soothes, Strengthens & Revitalizes
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
B-12 Extreme™ B-12 Extreme™
The Most Potent Vitamin B-12 on Earth
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health

Natural Remedies

Block food Cravings At Their Molecular Root Block food Cravings At Their Molecular Root
More Weight Loss than Any Other Discovery in Supplement History More Weight Loss than Any Other Discovery in Supplement History
The New Dual Activation Pain Relief Cream The New Dual Activation Pain Relief Cream
Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial
Vitamin K-2 – A Key Player in Cardiovascular and Bone Health Vitamin K-2 – A Key Player in Cardiovascular and Bone Health

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE AND SAVE 15% NOW*
Be the first to know about new products, special discounts and the latest health news. *New subscribers only

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map